Michael P. Stansky
CIK: 0001424204
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TriSalus Life Sciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 15, 2026TLSI
TriSalus Life Sciences, Inc.
Purchase(P)Indirect200K shares at avg. $2.50$500K - May 15, 2026TLSI
TriSalus Life Sciences, Inc.
Purchase(P)Direct410K shares at avg. $2.50$1.0M - May 14, 2026TLSI
TriSalus Life Sciences, Inc.
Award(A)Direct20.1K shares- - May 14, 2026TLSI
TriSalus Life Sciences, Inc.
Award(A)Direct23.5K shares- - Feb 23, 2026TLSI
TriSalus Life Sciences, Inc.
Purchase(P)Direct243.9K shares at avg. $4.10$1000K - Feb 23, 2026TLSI
TriSalus Life Sciences, Inc.
Purchase(P)Indirect117.2K shares at avg. $4.10$481K - Feb 4, 2026TLSI
TriSalus Life Sciences, Inc.
Award(A)DirectDirector Stock Option (right to buy)
92.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 15, 2026 | TLSI TriSalus Life Sciences, Inc. | Purchase(P) | 200,000 | $2.50 | $500,000 | Indirect |
| May 15, 2026 | TLSI TriSalus Life Sciences, Inc. | Purchase(P) | 410,000 | $2.50 | $1,025,000 | Direct |
| May 14, 2026 | TLSI TriSalus Life Sciences, Inc. | Award(A) | 20,089 | - | $0 | Direct |
| May 14, 2026 | TLSI TriSalus Life Sciences, Inc. | Award(A) | 23,501 | - | $0 | Direct |
| Feb 23, 2026 | TLSI TriSalus Life Sciences, Inc. | Purchase(P) | 243,900 | $4.10 | $999,990 | Direct |
| Feb 23, 2026 | TLSI TriSalus Life Sciences, Inc. | Purchase(P) | 117,198 | $4.10 | $480,512 | Indirect |
| Feb 4, 2026 | TLSI TriSalus Life Sciences, Inc. | Award(A) Director Stock Option (right to buy) | 92,537 | - | - | Direct |
1-7 of 7 transactions
About Stansky Michael P
Stansky Michael P (SEC CIK 0001424204) files insider reports with the SEC as Director of TriSalus Life Sciences, Inc. (TLSI).
Signal8 holds 5 ownership filings by Stansky Michael P (1 Form 3, 4 Form 4), filed between Feb 11, 2026 and May 18, 2026. Those filings report 7 transactions, from Feb 4, 2026 to May 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Stansky Michael P's filings is in WESTMINSTER, CO.
Recent filings by Stansky Michael P
- May 15, 2026: Open-market purchases of TLSI shares (2 lines, Form 4, code P).
- May 14, 2026: Grants or awards of TLSI shares (2 lines, Form 4, code A).
- Feb 23, 2026: Open-market purchases of TLSI shares (2 lines, Form 4, code P).
- Feb 4, 2026: Grant or award of TLSI derivative securities (Form 4, code A).
Other insiders filing for TriSalus Life Sciences, Inc. (TLSI)
- Cox Bryan F., Chief of Research
- Marshak Richard, Chief Commercial Officer
- Stevens Jennifer, Chief Regulatory Officer
- Szela Mary T, CEO and President
- Patience David, Chief Financial Officer
- Marshall Richard Henry, Chief Medical Officer